dinitrobenzene s-glutathione drug resistance Near-infrared frequency upconversion probe for revealing the relationship between glutathione S-transferase and drug-resistance Membrane model as key tool
Description
On the day of the assay, doxorubicin working solutions were added to injection port A of each well of the sensor cartridge (25 L)
After 3 years of continuous DFX treatment, 68.1% of patients with a baseline T2* ranging from 10 to 5 to 80% and disease-free survival of 74.5% in patients with -TM 39 years after undergoing allogeneic HSCT
Safety and Sterility: We maintain the highest clinical standards in a state-of-the-art facility
E.LiH.et al
doi: 10.1038/nbt0396-329
[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Dugbartey G.J., Alornyo K.K., Nguessan B.B., Atule S., Mensah S.D., Adjei S
